NCT01601119
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Please contact the Merck KGaA Communication Center For Locations, United Kingdom
Clinical trial condition
Relapsing Multiple Sclerosis
Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
69 public trials
9 recruiting studies
Relapsing Multiple Sclerosis trial results
Completed
Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis
NCT00906399
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
- Locations
-
- Research Site Phoenix, Arizona, United States
- Research Site Ponte Vedra Beach, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site Des Moines, Iowa, United States
NCT01034579
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States
Completed
Transition to Rebif New Formulation
NCT00619307
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Local Medical Information Paris, France
- Local Medical Information Munich, Germany
NCT01601080
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Please contact the Merck KGaA Communication Center For Recruiting Locations, United Kingdom
NCT00472797
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- EMD Serono, Inc. Rockland, Massachusetts, United States
NCT01199861
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Novartis Investigative Site Aalst, Belgium
- Novartis Investigative Site Brussels, Belgium
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Liège, Belgium
NCT01006941
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Danish Multiple Sclerosis Center, Rigshospitalet Copenhagen, Denmark
Completed
CDP323 Biomarker Study
NCT00726648
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Tooting, London, United Kingdom
- Croydon, Surrey, United Kingdom